Post‑Marketing Safety Study Obligations Explained
Post‑Marketing Safety Study Obligations Explained Understanding Post‑Marketing Safety Study Obligations Why Post‑Marketing Safety Studies Are Critical Approval of a drug or biologic does not eliminate the need for ongoing safety monitoring. Post‑marketing safety studies are designed to detect rare adverse events, assess long-term safety, and evaluate real‑world effectiveness. Regulatory authorities such as the FDA, EMA,…
Read More “Post‑Marketing Safety Study Obligations Explained” »